Sigyn Therapeutics, Inc. operates as a development-stage therapeutic technology company, which focuses on the treatment of life-threatening inflammatory conditions that are precipitated by cytokine storm syndrome. The company was founded by James A. Joyce and Craig P. Roberts on December 15, 2014 and is headquartered in San Diego, CA.